Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Local irradiation in combination with bevacizumab enhances radiation control of bone destruction and cancer-induced pain in a model of bone metastases.

Zwolak P, Dudek AZ, Bodempudi VD, Nguyen J, Hebbel RP, Gallus NJ, Ericson ME, Goblirsch MJ, Clohisy DR.

Int J Cancer. 2008 Feb 1;122(3):681-8.

2.

Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.

Dudek AZ, Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Farassati F.

Invest New Drugs. 2008 Feb;26(1):13-24. Epub 2007 Sep 6.

PMID:
17805485
3.

Combination of anti-angiogenic therapies reduces osteolysis and tumor burden in experimental breast cancer bone metastasis.

Bachelier R, Confavreux CB, Peyruchaud O, Croset M, Goehrig D, van der Pluijm G, Clézardin P.

Int J Cancer. 2014 Sep 15;135(6):1319-29. doi: 10.1002/ijc.28787. Epub 2014 Mar 3.

4.

Addition of receptor tyrosine kinase inhibitor to radiation increases tumour control in an orthotopic murine model of breast cancer metastasis in bone.

Zwolak P, Jasinski P, Terai K, Gallus NJ, Ericson ME, Clohisy DR, Dudek AZ.

Eur J Cancer. 2008 Nov;44(16):2506-17. doi: 10.1016/j.ejca.2008.07.011. Epub 2008 Aug 22.

PMID:
18723339
5.

Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion.

Park HC, Seong J, An JH, Kim J, Kim UJ, Lee BW.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1523-34.

PMID:
15817359
6.

The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception.

Vit JP, Ohara PT, Tien DA, Fike JR, Eikmeier L, Beitz A, Wilcox GL, Jasmin L.

Pain. 2006 Jan;120(1-2):188-201. Epub 2005 Dec 19.

PMID:
16360279
7.

Radiotherapy for palliation of symptoms in incurable cancer.

Hoegler D.

Curr Probl Cancer. 1997 May-Jun;21(3):129-83. Review.

PMID:
9202888
8.

Osteolysis and pain due to experimental bone metastases are improved by treatment with rapamycin.

Abdelaziz DM, Stone LS, Komarova SV.

Breast Cancer Res Treat. 2014 Jan;143(2):227-37. doi: 10.1007/s10549-013-2799-0. Epub 2013 Dec 11.

PMID:
24327332
9.

Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.

Bäuerle T, Hilbig H, Bartling S, Kiessling F, Kersten A, Schmitt-Gräff A, Kauczor HU, Delorme S, Berger MR.

Neoplasia. 2008 May;10(5):511-20.

10.

Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.

Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP, Wang JH.

Ann Surg Oncol. 2009 May;16(5):1403-11. doi: 10.1245/s10434-009-0343-6. Epub 2009 Mar 5.

PMID:
19263173
11.

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

Dings RP, Loren M, Heun H, McNiel E, Griffioen AW, Mayo KH, Griffin RJ.

Clin Cancer Res. 2007 Jun 1;13(11):3395-402.

12.

Palliative radiotherapy in the treatment of skeletal metastases.

Saarto T, Janes R, Tenhunen M, Kouri M.

Eur J Pain. 2002;6(5):323-30. Review.

PMID:
12160506
13.

Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

Demaria S, Kawashima N, Yang AM, Devitt ML, Babb JS, Allison JP, Formenti SC.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34.

14.

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T.

Int J Cancer. 2003 Oct 10;106(6):973-9.

15.

Radiation-induced alteration of pain-related signals in an animal model with bone invasion from cancer.

Seong J, Park HC, Kim J, Kim UJ, Lee BW.

Ann N Y Acad Sci. 2004 Dec;1030:179-86.

PMID:
15659796
16.
17.
18.

Clinical trials in metastatic breast cancer to bone: past--present--future.

Body JJ.

Can J Oncol. 1995 Dec;5 Suppl 1:16-27. Review.

PMID:
8853520
19.

Bevacizumab increases viral distribution in human anaplastic thyroid carcinoma xenografts and enhances the effects of E1A-defective adenovirus dl922-947.

Libertini S, Iacuzzo I, Perruolo G, Scala S, Ieranò C, Franco R, Hallden G, Portella G.

Clin Cancer Res. 2008 Oct 15;14(20):6505-14. doi: 10.1158/1078-0432.CCR-08-0200.

20.

The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.

Niang U, Kamer S, Ozsaran Z, Haydaroglu A, Kilciksiz S.

J BUON. 2009 Apr-Jun;14(2):245-9.

PMID:
19650174

Supplemental Content

Support Center